UNSPSC 51182009: Methyltestosterone

This classification denotes a therapeutic androgen with the molecular formula C20H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V9EFU16ZIF, chemically known as testosterone, 17-methyl- but generally known as 17-methyltestosterone, which bears US NIH Compound Identifier 6010. European Medicines Agency schedules Methyltestosterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08876MIG.

UNSPSC 51182009 Methyltestosterone, a Commodity code, covers the procurement of methyltestosterone — a synthetic androgenic anabolic steroid used in medical and clinical settings — by state and local health agencies, correctional facilities, and public health departments. State and local governments acquire this pharmaceutical product primarily for inmate healthcare programs, institutional medical services, and public health clinic dispensing where hormone replacement or androgenic therapy is clinically indicated. The code encompasses the purchase of methyltestosterone in tablet, injectable, and other pharmaceutical formulations from licensed pharmaceutical suppliers and wholesalers meeting state pharmacy board regulations and DEA scheduling requirements.

The source provides no recent state or local contract opportunities tagged to this code. Without visibility into active solicitations, geographic concentration, issuing-body frequency, or representative RFPs or RFQs, no assessment of current market activity, jurisdictional demand, or response timeline can be drawn from available data.